Prevent Intravenous Therapy (IV) Contamination by Addition of Magnesium Oxide Nanoparticles to Silicone Rubber

Main Article Content

Auda Jabbar Braihi
Jaleel Kareem Ahmed
Rami Sattar Jabbar

Abstract

Antibacterial material nanocomposites are prepared to manufacture intravenous therapy (IV). These composites prepared by adding Magnesium oxide nano powder (MgO NPs) with a different percent (3, 6, and 9 wt %) to Silicone rubber (SR). The activity of this antibacterial material was inspected against S. aureus and E.coli microorganisms by using Agar Well Diffusion method.


Results showed that the addition of MgO NPs to SiR causes the following enhancement the antibacterial activity against E.coli and S.aureus by 7.1% and 27.1% respectively, increasing tensile strength by 65.5%, increasing the hardness by11.25%, increasing the wear resistance by 84.5%, increasing surface bearing index (Sbi) by 80.5% , increasing in core fluid retention (Sci) by 8.5%,  decreasing surface roughness (Sa) by 65%, decreasing core roughness depth (Sk) by 67% and  enhancement the wettability by decreases contact angle to minimum value.

Downloads

Download data is not yet available.

Article Details

How to Cite
[1]
A. J. Braihi, J. K. Ahmed, and R. S. Jabbar, “Prevent Intravenous Therapy (IV) Contamination by Addition of Magnesium Oxide Nanoparticles to Silicone Rubber”, JUBES, vol. 27, no. 1, pp. 409 - 417, Feb. 2019.
Section
Articles